de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as firstline treatment in advanced colorectal cancer. J Clin Oncol 18(16): 2938-2947, 2000.
Andre T, Louvet C, Maindrault-Goebel F, et al: CPT-11 addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOL-FIRI) for pretreated metastatic colorectal cancer: GERCOR. Eur J Cancer 35(9): 1343-1347, 1999.
Sastre J, Marcuello E, Masutti B, et al: Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer. J Clin Oncol 23(15): 3545-3551, 2005.
M Ychou, J Raoul, J Douillard, et al: A phase III randomized trial of LV 5 FU 2 + CPT-11 vs. LV 5 FU 2 alone in adjuvant high risk colon cancer (FNCL-CC Accord 02/FFCD 9802). Proc ASCO, 2005.
E Van Cutsem, R Labianca, D Hossfeld, et al: Randomized phase III trial comparing infusion irinotecan/5-FU/IF versus 5-FU/FA in stage III colon cancer patients (PETACC 3). Proc ASCO 2005.